XML 18 R8.htm IDEA: XBRL DOCUMENT

General information	12 Months Ended
General information	Jun. 30, 2025
Disclosure [Abstract]
General information	Note 1. General information The consolidated financial statements cover Kazia Therapeutics Limited (the “Consolidated Entity”, the “Company” or “Kazia”) as a consolidated entity which consists of Kazia Therapeutics Limited and its subsidiaries. The consolidated financial statements are presented in Australian dollars, which is Kazia Therapeutics Limited’s functional and reporting currency. Kazia Therapeutics Limited is a listed public company limited by shares, incorporated and domiciled in Australia. Its registered office and principal place of business is: Three International Towers Level 24, 300 Barangaroo Avenue Sydney NSW 2000 The consolidated financial statements were authorized for issue, in accordance with a resolution of Directors, on 7 November 2025. The Directors have the power to amend and reissue the consolidated financial statements.